Scientific Program
IC198 - Everything About Biosimilars: How, Why and What to Choose
Date
14/03/2024
Hall
HALL 8 ( Glass Room )
From
12:15
To
13:30
Chief Instructor Membership Number
S13838
Chief Instructor Name
Dr.Ashish Sharma
Title
Everything About Biosimilars: How, Why and What to Choose
Summary
Biologics since their inception have revolutionised the treatment protocol by directly targeting the molecular pathophysiology of many diseases. But their development was restricted due to a demanding R&D process making them costly therapy. With development of biosimilars, the biologics which are similar in structure, efficacy, and safety to the reference molecules, are well regulated; the cost of treatment has reduced up to 25%. Sensing the large business opportunity, there is a wave of biosimilars being launched globally for retinal diseases. India with its vast experience with early adoption can become the leaders in the segment. The course aims to provide an overview of biosimilars, their regulations and drug trials, safety, efficacy, financial implications, future prospects and biobetters in form of didactic lectures. The course dedicates time for panel discussion and audience interaction for a better understanding of the subject.
Resume
Chief Instructor is known as a world leader on this topic with the highest number of publications globally in this area.
Membership No
Name
Topic
Order no
Duration
Consented
K20052
Dr.Nilesh Kumar
Biologics, Biosimilars and Biobetter- What do they mean
1
10
S13838
Dr.Ashish Sharma
Understanding the regulatory and drug trial design of biosimilars (9 min)
2
10
D02855
Dr.Mangat Ram Dogra
Biosimilars- Lessons to be learnt from India
3
10
T14981
Dr.Satya Prakash Tiwary
The financial implications of biosimilars
4
10
C10922
Dr.Debdulal Chakraborty
The real-world experience of biosimilars
5
10
Panel discussion : 25 Mins )
